Ignite Creation Date:
2025-12-24 @ 12:43 PM
Ignite Modification Date:
2026-02-02 @ 5:22 AM
Study NCT ID:
NCT02027961
Status:
COMPLETED
Last Update Posted:
2019-05-17
First Post:
2013-11-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone
Sponsor:
MedImmune LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2018-04-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-04-24
Completion Date Type:
ACTUAL
First Submit Date:
2013-11-20
First Submit QC Date:
None
Study First Post Date:
2014-01-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-15
Last Update Post Date:
2019-05-17
Last Update Post Date Type:
ACTUAL